REG endpoint validation: Do database asthma control measures predict future risk?
G. Brusselle, R. J. Martin, A. Burden, A. Dima, E. Pizzichini, J. Holbrook, N. G. Papadopoulos, T. Popov, G. Colice, H. K. Reddel, J. von Ziegenweidt, A. Chisholm, D. Price (Ghent, Florianópolis, Belgium; Denver, Baltimore, Washington, United States Of America; Cambridge, Aberdeen, United Kingdom; Amsterdam, Netherlands; Athens, Greece; Sofia, Bulgaria; Sydney, Australia)
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Disease area: Airway diseases
AbstractAim: Improved understanding of patient characteristics associated with exacerbations (EXBs) may provide opportunity to minimize future risk. We assessed whether database asthma control can predict future EXBs.Methods: Used a research database to select clinical records of patients aged 18–60yrs with an asthma diagnosis, continuous records over 1 baseline & 1 outcome yr and no other chronic respiratory disease or maintenance oral steroids. Two baseline control measures were evaluated: risk domain asthma control (RDAC) & overall control (OAC). RDAC was absence of: exacerbations, unplanned asthma-related out patient appointments, and antibiotics with evidence of respiratory review (ABX). OAC was: RDAC+average salbutamol £200µg/day. RDAC/OAC components predictive of outcome EXBs in univariable models were entered into a multivariable model and stepwise reduced. EXBs were: oral steroid courses with evidence of respiratory review (OS), asthma-related hospital admission or emergency room [ER] attendance.Results: Of 1558 patients (60% female), 73% and 42% satisfied criteria for RDAC and OAC control, respectively, at baseline.Baseline Predictors of EXB risk | Rate Ratio(95%CI) | p-value | Univariable analysis | RDAC (uncontrolled)* | 2.78(2.04–3.70) | <0.001 | OAC (uncontrolled)* | 1.69(1.23–2.33) | <0.001 | | OS | 0 | 1.00 | | | 1 | 2.33(1.58–3.42) | <0.001 | | £2 | 2.53(1.54–4.17) | | ER attendance | 0 | 1.00 | | | 1 | 1.58(1.06–2.34) | <0.001 | | £2 | 2.43(1.59–3.71) | | ER attendance | 0 | 1.00 | 0.037 | | £1 | 2.21(1.05–4.66) | |
Conclusions: Classification as RDAC or OAC at baseline predicted lower EXB rates in the following year. OS, ABX and asthma-related ER attendance independently predicted increased EXB risk regardless of “current control” as indicated by salbutamol use. *Controlled RR=1.00 |